Literature DB >> 29769999

Invasive serogroup W Neisseria meningitidis (MenW) in Ontario, Canada shows potential clonal replacement during the period January 1, 2009 to June 30, 2016.

R S Tsang1, S L Deeks2,3, K Wong2, A Marchand-Austin2, F B Jamieson2,3.   

Abstract

BACKGROUND: In Ontario, serogroup W Neisseria meningitidis (MenW) accounts for a small percentage of all invasive meningococcal disease (IMD) and between 2010 and 2014, only zero to three confirmed cases occurred per year. However, between August 2015 and June 2016, six culture confirmed MenW IMD cases were reported in Ontario.
OBJECTIVE: All MenW IMD cases in Ontario between January 1, 2009 and June 30, 2016 were reviewed and the N. meningitidis strains involved were characterized.
METHODS: MenW cases were identified in the Integrated Public Health Information System byf Public Health Ontario. MenW isolates were characterized at the National Microbiology Laboratory.
RESULTS: Of the thirteen MenW IMD cases, six were due to isolates typed as sequence type (ST)-22 clonal complex (cc), six were of ST-11 cc, and one ST-167 cc. Most (83%) MenW cases due to the ST-22 cc occurred prior to 2012 while all six MenW cases due to ST-11 cc happened since May 2014. The six MenW ST-11 isolates appeared to be clonal.
CONCLUSION: It appears that a genetic shift in the invasive MenW isolates has occurred in Ontario in 2014 with the ST-11 clone replacing the traditional ST-22 clone.

Entities:  

Year:  2016        PMID: 29769999      PMCID: PMC5757677          DOI: 10.14745/ccdr.v42i12a06

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  28 in total

1.  Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.

Authors:  Isabelle Parent du Châtelet; Yves Traore; Bradford D Gessner; Aude Antignac; B Naccro; Berthe-Marie Njanpop-Lafourcade; Macaire S Ouedraogo; Sylvestre R Tiendrebeogo; Emmanuelle Varon; Muhammed K Taha
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

2.  Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada.

Authors:  D A Kertesz; M B Coulthart; J A Ryan; W M Johnson; F E Ashton
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

3.  Meningococcal disease in Canada. Surveillance summary to 1987.

Authors:  P V Varughese; A O Carter
Journal:  Can Dis Wkly Rep       Date:  1989-04-29

4.  [Emergence of W135 meningococcal serogroup in Chile during 2012].

Authors:  M Teresa Valenzuela; Gabriela Moreno; Alejandra Vaquero; Mabel Seoane; J Carlos Hormazábal; M Paz Bertoglia; Doris Gallegos; Viviana Sotomayor; Jorge Díaz
Journal:  Rev Med Chil       Date:  2013-08       Impact factor: 0.553

5.  Neisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil.

Authors:  David E Barroso; Terezinha M P P Castiñeiras; Adriana C Cabral; Ana C P Vicente; Maria C Rebelo; Elaine O Cerqueira; Mary M Tulenko; Jane W Marsh; Mary G Krauland; Lee H Harrison
Journal:  J Infect       Date:  2013-01-12       Impact factor: 6.072

6.  Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.

Authors:  F E Ashton; J A Ryan; A Borczyk; D A Caugant; L Mancino; D Huang
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 7.  Population genetics and molecular epidemiology of Neisseria meningitidis.

Authors:  D A Caugant
Journal:  APMIS       Date:  1998-05       Impact factor: 3.205

8.  Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.

Authors:  Jean-François Aguilera; Anne Perrocheau; Christine Meffre; Susan Hahné
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

9.  Spread of Neisseria meningitidis serogroup W clone, China.

Authors:  Haijian Zhou; Wei Liu; Li Xu; Lili Deng; Qiuyun Deng; Jiatong Zhuo; Zhujun Shao
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

10.  Serogroup W135 meningococcal disease, The Gambia, 2012.

Authors:  M Jahangir Hossain; Anna Roca; Grant A Mackenzie; Momodou Jasseh; Mohammad Ilias Hossain; Shah Muhammad; Manjang Ahmed; Osuorah Donatus Chidiebere; Ndiaye Malick; S M Bilquees; Usman N Ikumapayi; Baba Jeng; Baba Njie; Mamady Cham; Beate Kampmann; Tumani Corrah; Stephen Howie; Umberto D'Alessandro
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

View more
  6 in total

1.  Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016.

Authors:  Rsw Tsang; L Hoang; G J Tyrrell; G Horsman; P Van Caeseele; F Jamieson; B Lefebvre; D Haldane; R R Gad; G J German; G Zahariadis
Journal:  Can Commun Dis Rep       Date:  2017-07-06

Review 2.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

3.  Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

Authors:  R S Tsang; L Hoang; G J Tyrrell; J Minion; P Van Caeseele; J V Kus; B Lefebvre; D Haldane; R Garceau; G German; G Zahariadis; B Hanley
Journal:  Can Commun Dis Rep       Date:  2019-06-06

4.  Risk factors for carriage of meningococcus in third-level students in Ireland: an unsupervised machine learning approach.

Authors:  Richard J Drew; Desirée Bennett; Sinéad O'Donnell; Robert Mulhall; Robert Cunney
Journal:  Hum Vaccin Immunother       Date:  2021-06-24       Impact factor: 4.526

Review 5.  A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.

Authors:  Lidia C Serra; Laura J York; Amgad Gamil; Paul Balmer; Chris Webber
Journal:  Infect Dis Ther       Date:  2018-03-17

Review 6.  Vaccination strategies for the prevention of meningococcal disease.

Authors:  Scott Vuocolo; Paul Balmer; William C Gruber; Kathrin U Jansen; Annaliesa S Anderson; John L Perez; Laura J York
Journal:  Hum Vaccin Immunother       Date:  2018-04-13       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.